Description
Vatalanib is an inhibitor of VEGFR1/2/3. It decreases tumor growth in models of human glioma when administered with HET0016, a 20-HETE synthesis inhibitor.
Product Unit Size | Cost | Quantity | Stock |
---|
Vatalanib is an inhibitor of VEGFR1/2/3. It decreases tumor growth in models of human glioma when administered with HET0016, a 20-HETE synthesis inhibitor.
Cas No. | 212141-54-3 |
---|---|
Purity | ≥98% |
Formula | C20H15ClN4 |
Formula Wt. | 346.82 |
Chemical Name | Vatalanib |
IUPAC Name | N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine |
Synonym | PTK-787, PTK 787, PTK787, ZK-222584, ZK 222584, ZK222584, CGP-797870, ZK232934 |
Solubility | Solubility in DMSO - ~100 mg/mL. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Shankar A., Borin T., et al. Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma. Onco Target Ther. 9:1204-19 (2016). PMID: 27022280.
Mixture of quaternary ammonium salts, cationic ...
Statin; HMG-CoA reductase inhibitor, potential ...
Used to study embryonic cloning; microtubule po...
Alters intracellular glutathione levels.
First generation fluoroquinolone antibiotic.
Non-selective cannabinoid receptor agonist.
CDK4/6 inhibitor.
Purine derivative; CDK inhibitor.
Peptide, neutral ionophore.
Aromatase inhibitor.
Sesquiterpene lactone found in Tanacetum; TRPA1...
Flavonoid found in various plant sources; GABA-...
Non-selective CB receptor agonist.
Endogenous peptide hormone fragment, involved i...
Abl (T315I) inhibitor.
RARα/β agonist.
p110δ PI3K inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
β-lactam; penicillin binding protein inhibitor...
Polyphenol derivative of caffeic acid found in ...